Is Scienture Holdings, Inc. (SCNX) overvalued? · rev $400.0K
Scienture Holdings, Inc. (SCNX) is a pharmaceutical retailers company listed on NASDAQ.
This page asks whether Scienture Holdings, Inc. (SCNX) looks expensive on cached numbers — not a short thesis.
Latest reported SCNX revenue for 2026-06-30 was $400.0K. Net income was -$6.2M. SCNX currently screens at market cap $15.8M.
SCNX currently screens at market cap $15.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SCNX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SCNX stock page for the full model, not this heading.
Not investment advice.